These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32176655)

  • 1. Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
    Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Pachi I; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2020; 10(2):481-487. PubMed ID: 32176655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study.
    Koros C; Simitsi AM; Papagiannakis N; Bougea A; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Parkinsonism Relat Disord; 2021 Mar; 84():1-4. PubMed ID: 33508700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease.
    Emmanouilidou E; Papagiannakis N; Kouloulia S; Galaziou A; Antonellou R; Papadimitriou D; Athanasiadou A; Bozi M; Koros C; Maniati M; Vekrellis K; Ioannou PC; Stefanis L
    Parkinsonism Relat Disord; 2020 Apr; 73():35-40. PubMed ID: 32234683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Koros C; Simitsi AM; Papagiannakis N; Bougea A; Prentakis A; Papadimitriou D; Pachi I; Beratis I; Stanitsa E; Angelopoulou E; Antonelou R; Bregianni M; Lourentzos K; Papageorgiou SG; Bonakis A; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2023; 13(5):811-818. PubMed ID: 37424476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
    Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
    Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein A53T mutation is not frequent on a sample of Brazilian Parkinson's disease patients.
    Longo GS; Pinhel MA; Gregório ML; Oliveira BA; Quinhoneiro DC; Tognola WA; Oliveira FN; Martins DP; Cezario SM; Sado CL; Nakazone MA; Calastri MC; Souza DR
    Arq Neuropsiquiatr; 2015 Jun; 73(6):506-9. PubMed ID: 26083886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study.
    Simitsi AM; Koros C; Stamelou M; Beratis I; Efthymiopoulou E; Papadimitriou D; Bougea A; Picillo M; Stanitsa E; Papagiannakis N; Antonelou R; Pachi I; Papageorgiou SG; Barone P; Stefanis L
    Parkinsonism Relat Disord; 2022 May; 98():72-74. PubMed ID: 35490542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA
    Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.
    Papagiannakis N; Koros C; Stamelou M; Simitsi AM; Maniati M; Antonelou R; Papadimitriou D; Dermentzaki G; Moraitou M; Michelakakis H; Stefanis L
    Neurosci Lett; 2018 Apr; 672():145-149. PubMed ID: 29129675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers.
    Murueta-Goyena A; Cipriani R; Carmona-Abellán M; Acera M; Ayo N; Del Pino R; Tijero B; Fernández-Valle T; Gabilondo I; Zallo F; Matute C; Sánchez-Pernaute R; Khurana V; Cavaliere F; Capetillo-Zarate E; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2022 Mar; 96():29-35. PubMed ID: 35149357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson's Disease Diagnosis and Duration.
    Schaeffer E; Kluge A; Schulte C; Deuschle C; Bunk J; Welzel J; Maetzler W; Berg D
    J Parkinsons Dis; 2024; 14(4):667-679. PubMed ID: 38669557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.
    Oosterveld LP; Verberk IMW; Majbour NK; El-Agnaf OM; Weinstein HC; Berendse HW; Teunissen CE; van de Berg WDJ
    Mov Disord; 2020 Feb; 35(2):288-295. PubMed ID: 31737952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.
    Ritz B; Rhodes SL; Bordelon Y; Bronstein J
    PLoS One; 2012; 7(5):e36199. PubMed ID: 22615757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease.
    Hoffman-Zacharska D; Koziorowski D; Ross OA; Milewski M; Poznanski JA; Jurek M; Wszolek ZK; Soto-Ortolaza A; Awek JAS; Janik P; Jamrozik Z; Potulska-Chromik A; Jasinska-Myga B; Opala G; Krygowska-Wajs A; Czyzewski K; Dickson DW; Bal J; Friedman A
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1057-1060. PubMed ID: 23916651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
    Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
    Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.